Ad hominem You think that Thomson is a swing day trader like you and is not burying 4050? Guess you made lots of money on the $7 to $4 short over the last week? Thomson took years to decide on next phase 2 candidate of 4050 as IPF when markets for kidney and liver were huge and results strong - as in "penicillin" as quoted by Laurin and Moran. So, you're saying they lied and Pritchard is telling the truth? Ryplazim? They spent $100's of millions for $70M from PRV and $5M for plasma division which include IVIG and many others. Sure, kid. Can you quote anything from foundational value argument of any analyst? Didn't think so..